Sign in

What researchers published on Ovarian cancer

43,193 papers, newest first.

Showing 40 of 43,193

  • Case reportFamilial Ovarian Teratoma With Neural Tissue Expression and Anti-NMDAR Encephalitis.Neurology(R) neuroimmunology & neuroinflammation
  • Matrix Softness and Fluid Shear Force Act Through TRPV4 to Promote Ovarian Cancer Stemness.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
  • ReviewTumo​r-associated macrophages in ovarian, prostate, thyroid and pancreatic neuroendocrine tumors: molecular crosstalk and therapeutic perspectives.Molecular biology reports
  • Generation of mixed ovarian cancer and fibroblast spheroids by bioprinting.In vitro models
  • Cross-database thromboembolic reporting signals for ovarian cancer therapies: a focus on bevacizumab.BMC cancer
  • [Emphasis on the standardization of initial treatment for ovarian cancer].Zhonghua yi xue za zhi
  • ReviewAdvances in Biomarker Discovery for Early Ovarian Cancer Diagnosis.Cells
  • Diagnostic Performance of Contrast-Enhanced Computed Tomography in Predicting Lymph Node Metastasis in Epithelial Ovarian Cancer: The Added Value of Combining CT with CA-125.Diagnostics (Basel, Switzerland)
  • Infrared Treatment Alters the Chemical Profile and In Vitro Bioactivity of Jojoba Oil: Antimicrobial, Biofilm Formation Inhibition and Ovarian Cancer Cell Responses.International journal of molecular sciences
  • FABP4 is associated with ROS-dependent ferroptosis inhibition and platinum resistance in ovarian cancer.Tissue & cell
  • ReviewImmune Resistance and Anti-Tumor Immunity in the Ovarian Tumor Microenvironment.Cells
  • PADI2 facilitates progression and cisplatin resistance of epithelial ovarian cancer via m6A methylation.iScience
  • Biologic and immunologic characteristics of ovarian cancers that are associated with p53 autoantibodies.Cancer
  • ReviewPrognostic Value of the KELIM Score Versus Conventional CA-125 Kinetics in Ovarian Cancer: A Systematic Review and Meta-Analysis.Diagnostics (Basel, Switzerland)
  • Comparison of Sonidegib and Vismodegib Efficiency in Drug-Sensitive and Resistant Ovarian Cancer Cell Lines-2D and 3D Model Study.International journal of molecular sciences
  • ReviewThe Role of D-3-Phosphoglycerate Dehydrogenase (PHGDH) in Chemoresistance in Ovarian Cancer: Molecular Insights and Therapeutic Potential.International journal of molecular sciences
  • Multicenter Evaluation of Decentralized Homologous Recombination Deficiency Testing for Enhanced Molecular Diagnosis of Ovarian Cancer.International journal of molecular sciences
  • A leakage-aware and interpretable machine learning framework for ovarian cancer prediction using the PLCO screening dataset.Frontiers in oncology
  • Hypoxia-Associated Glycolytic-Lipogenic Reprogramming and Impaired Antigen Presentation in SPP1+ Tumor-Associated Macrophages in Ovarian Cancer.International journal of molecular sciences
  • Correction: Gralewska-Zając et al. Liposomal Vitamin C as a Modulator of the Efficacy of Ceralasertib Therapy in Ovarian Cancer. Int. J. Mol. Sci. 2026, 27, 2630.International journal of molecular sciences
  • ReviewFolate Receptor Alpha (FRα/FOLR1) in Cancer: Diagnostic, Prognostic or Predictive Biomarker? A Critical Review of Its Clinical Utility.International journal of molecular sciences
  • Comparison of Survival Outcomes with First-Line PARP Inhibitor Maintenance According to BRCA Mutation and Homologous Recombination Deficiency Status in Advanced Ovarian Cancer: A Single-Center Retrospective Cohort Study.Cancers
  • ReviewExtracellular Vesicle-Associated Epithelial-Mesenchymal Plasticity (EMP) as a Driver of Metastatic Evolution and Therapeutic Resistance in Ovarian Cancer.Cancers
  • Platelet-Derived Extracellular Vesicles for the Diagnosis of Ovarian Cancer.Cancers
  • "Hearing the Ovarian Cancer Whisper": A Pipeline Program Introducing Medical Students to Gynecologic Oncology, Focusing on the Diagnosis and Management of Ovarian Cancer.Medical science educator
  • Minimally invasive surgery improves surgical and analgesic outcomes in overweight or obese patients with borderline ovarian tumors: A retrospective cohort study.Medicine
  • Compartment-Resolved Profiling Identifies Shared Stromal Programs and Clarifies Molecular Subtype Origins in Ovarian Cancer.Cancer research
  • ReviewCellular senescence in ovarian cancer: context-dependent effects on tumor immunity and therapy response.Frontiers in immunology
  • Risk Factor Profiles May Differ Between Younger-Onset and Late-Onset Colorectal Cancer: An Exploratory Analysis of Individual and Cumulative Risk Factors Among the Prostate, Lung, Colorectal and Ovarian Cohort.Asia-Pacific journal of clinical oncology
  • Multi-omics-constrained kinetic models quantify pathway rewiring and predict metabolic vulnerabilities in BRCA1-deficient ovarian cancer.Cell systems
  • Clinical characteristics and treatment strategies of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis based on a case series.Frontiers in neurology
  • Tuberculous Salpingo-Oophoritis Mimicking Ovarian Malignancy: A Case Report of a Diagnostic Dilemma.Clinical case reports
  • MRPL47 as a mitochondrial biomarker for early detection and therapeutic response in ovarian cancer.Molecular therapy. Oncology
  • Surgical opportunities for primary prevention of high-grade serous ovarian cancer: a procedure-level analysis of opportunistic salpingectomy.Journal of ovarian research
  • Perillaldehyde (PAE) Regulates Ovarian Cancer by Modulating HSP70 and Regulating the PI3K/AKT Signaling Pathway.Archives of biochemistry and biophysics
  • Trial resultPamiparib plus surufatinib with ctDNA monitoring in platinum-resistant ovarian cancer after PARP inhibitor progression: a phase Ib/II trial (POST-PARPi).BMC medicine
  • AIF promotes ovarian cancer progression by competitively binding TRAP1 to stabilize MtCK1 to drive phosphocreatine synthesis.Journal of translational medicine
  • Fertility-sparing surgery for early-stage epithelial ovarian cancer: evolving criteria for patient selection.Japanese journal of clinical oncology
  • Randomised trialFuzuloparib in combination with apatinib versus fuzuloparib alone for recurrent ovarian cancer: a randomized, open-label, phase 2 trial.Journal of ovarian research
  • PD-L1 expression in epithelial ovarian cancer and survival: a retrospective cohort study.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia